Mechanism of Action and Pharmacodynamics
As the first representative of the synthetic interferon inducer group, tilorone exhibits a comprehensive effect on the immune system. Its pharmacodynamics is based on three main effects:
- Interferon Induction: The drug has a broad spectrum of induction, stimulating the production of all major types of endogenous interferons — alpha, beta, and gamma.
- Antiviral Activity: Through interferon production, nonspecific cellular defense is realized. The drug is active against a wide range of pathogens, including both DNA-containing and RNA-containing viruses.
- Immunomodulatory Effect: Amixinum stimulates humoral immunity by activating antibody production. In addition, it has a positive effect on the cellular arm, normalizing the ratio of T-helper cells to T-suppressor cells.
Indications for Use
The spectrum of indications includes both monotherapy and inclusion in combined treatment regimens for infectious diseases.
Prevention and Treatment:
- Influenza and other acute respiratory viral infections (ARVI).
Treatment of Viral Infections:
- Viral hepatitis (A, B, C).
- Herpesvirus infections: herpes simplex virus (including urogenital forms), varicella-zoster virus (shingles), cytomegalovirus infection.
- Viral encephalomyelitis (neuroviral diseases).
As Part of Combination Therapy:
- Urogenital and respiratory chlamydia.
- Infectious-allergic diseases.
- Secondary immunodeficiency states.
Side Effects and Tolerability
In clinical practice, Amixin is generally well tolerated. However, the following adverse reactions may occur during therapy:
- Dyspepsia (gastrointestinal disturbances).
- Transient chills.
- Increase in overall body tone.
It is important to note that the development of these side effects typically does not require discontinuation of the drug.
Prescribing and Administration
The drug is administered strictly orally, taken after meals. A single dose for adults is typically 0.125–0.25 g (1–2 tablets).
Critical Note for Clinicians: According to pharmacological textbooks, a convincing evidence base for the efficacy of tilorone in rigorous clinical trials is lacking. This must be considered when choosing a treatment strategy, especially for severe viral infections.
Prescription Example:
Rp.: Tab. Amixini 0,125 D.t.d. N. 6 S. Per os, 1 tablet (0.125 g) after meals according to the prescribed regimen.